J. Durant
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 33
- HIV/AIDS Research and Interventions 27
- Virology 37
- HIV Research and Treatment 36
- Co-authors
- P. Dellamonica (54 shared papers)Philippe Clevenbergh (12 shared papers)Philippe Halfon (6 shared papers)N Montagne (5 shared papers)CAB Boucher (2 shared papers)Pascal Del-Giudice (1 shared paper)Pere Simonet (2 shared papers)R. Garraffo (12 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)AIDS (4 papers)Frontiers in Medicine (4 papers)HIV Clinical Trials (4 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
J. Durant
87 papers receiving 1.8k citations
J. Durant's Hit Papers
Peers
Comparison fields: 5 of 105
- Virology 1.1k
- Infectious Diseases 1.3k
- Emergency Medicine 250
- Hepatology 135
- Epidemiology 380
Countries citing papers authored by J. Durant
This map shows the geographic impact of J. Durant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Durant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Durant more than expected).
Fields of papers citing papers by J. Durant
This network shows the impact of papers produced by J. Durant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Durant. The network helps show where J. Durant may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Durant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial Hit paper breakdown → | 1999 | 559 |
| 2 | 2000 | 182 | |
| 3 | 2000 | 90 | |
| 4 | 2002 | 75 | |
| 5 | 2009 | 66 | |
| 6 | 2013 | 47 | |
| 7 | 2002 | 41 | |
| 8 | 2011 | 36 | |
| 9 | 2017 | 30 | |
| 10 | 2013 | 29 | |
| 11 | 2006 | 29 | |
| 12 | 1993 | 29 | |
| 13 | 2000 | 28 | |
| 14 | 2015 | 26 | |
| 15 | 1997 | 25 | |
| 16 | 1998 | 24 | |
| 17 | 2003 | 23 | |
| 18 | 2015 | 23 | |
| 19 | 1960 | 23 | |
| 20 | 1998 | 21 |
About J. Durant
J. Durant is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Pharmacology, having authored 91 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (36 papers), HIV/AIDS drug development and treatment (33 papers), HIV/AIDS Research and Interventions (27 papers), HIV-related health complications and treatments (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Hepatitis C virus research (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.3k citations), Emergency Medicine (250 citations), Hepatology (135 citations) and Epidemiology (380 citations). J. Durant has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include P. Dellamonica, Philippe Clevenbergh, Philippe Halfon, N Montagne, CAB Boucher, Pascal Del-Giudice, Pere Simonet, R. Garraffo, P. Del Giudice and Jonathan Schapiro. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, AIDS, Frontiers in Medicine and HIV Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.